Eptinezumab (Vyepti) Side Effects: What to Expect and Management
Eptinezumab-jjmr (Vyepti) is a CGRP antagonist administered IV quarterly for migraine prevention. Most side effects are mild and transient.
Common Side Effects (≥2% and >Placebo)
- Injection Site Reactions: Pain, erythema, bruising, swelling, pruritus (typically mild, resolve in days).
- Upper Respiratory Tract Infection: Nasopharyngitis, cold symptoms.
- Headache/Migraine: Paradoxical worsening (rare; may reflect disease fluctuation).
- Nasal Congestion, Pharyngitis, Cough
Less Common but Notable
- Hypersensitivity reactions (rash, urticaria, angioedema, anaphylaxis — rare; observe post-infusion)
- Fatigue, nausea, dizziness
Management
- Pre-hydrate; slow infusion rate if reactions occur.
- Topical cold compress, OTC antihistamine/analgesic for injection site symptoms.
- Report persistent/severe symptoms to prescriber.
- Pregnancy: Insufficient data; registry exists. Discuss risk/benefit.
Key Points
- No laboratory monitoring required.
- No hepatic/renal dose adjustment.
- Can be used with acute migraine meds (triptans, gepants, NSAIDs).
- Onset of prevention: some effect week 1; maximal by week 4.
Illness - Related Articles
- Candida Albicans: Symptoms, Causes & Treatment Options
- Hair Loss and Vitamin Deficiency: Understanding Beriberi & Pellagra
- Recognizing Health Issues: Common Symptoms & What to Watch For
- Understanding Pulse Oximeter Inaccuracy: Causes & Solutions
- Vicks Comfort Flex Thermometer Troubleshooting Guide: Fast & Accurate Readings
- Recognizing Serious Illness: Red Flags Requiring Urgent Medical Attention
- Top Foods to Ease Flu Symptoms & Boost Immunity
